RonaldJ.MattsonMD

General Surgery • Bryn Mawr, PA

Physician

Join to view full profile

Are you Dr. Mattson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
830 Old Lancaster Rd.
Suite 306
Bryn Mawr, PA 19010
Phone+1 610-527-1185

Fax+1 610-527-1940
Is this information wrong?

Summary

Dr. Ronald Mattson, MD is a general surgeon in Bryn Mawr, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Bryn Mawr Hospital and Paoli Hospital.

Education & Training

Main Line Health System/Lankenau Medical CenterResidency, Surgery, 1971 - 1976
Lewis Katz School of Medicine at Temple UniversityClass of 1971

Certifications & Licensure

PA State Medical License 1972 - 2024

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Join now to see all

Publications & Presentations

PubMed

Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
Lodge, N. J.,Li, Y. W.,Chin, F. T.,Dischino, D. D.,Zoghbi, S. S.,Deskus, J. A.,Mattson, R. J.,Imaizumi, M.,Pieschl, R.,Molski, T. F.,Fujita, M.,Dulac, H.,Zaczek, R.,Br...> ;Nucl. Med. Biol.. 2014 May 06
Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
Ditta, J. L.,Denhart, D. J.,Deskus, J. A.,Epperson, J. R.,Meng, Z.,Gao, Q.,Mattson, G. K.,Lapaglia, M. A.,Taber, M. T.,Molski, T. F.,Lodge, N. J.,Mattson, R. J.,Macor,...> ;Bioorg. Med. Chem. Lett.. 2013 May 15
Potential CRF1R PET imaging agents: 1-Fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones.
Denhart, D. J.,Zuev, D.,Ditta, J. L.,Hartz, R. A.,Ahuja, V. T.,Mattson, R. J.,Huang, H.,Mattson, G. K.,Zueva, L.,Nielsen, J. M.,Kozlowski, E. S.,Lodge, N. J.,Bronson, ...> ;Bioorg. Med. Chem. Lett.. 2013 Apr 1
Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
King, H.D., Meng, Z., Deskus, J.A., Sloan, C.P., Gao, Q., Beno, B.R., Kozlowski, E.S., Lapaglia, M.A., Mattson, G.K., Molski, T.F., Taber, M.T., Lodge, N.J., Mattson, ...> ;J Med Chem. 2010 Nov 11
A strategy to minimize reactive metabolite formation: discovery of (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5...
Hartz, R.A., Ahuja, V.T., Zhuo, X., Mattson, R.J., Denhart, D.J., Deskus, J.A., Vrudhula, V.M., Pan, S., Ditta, J.L., Shu, Y., Grace, J.E., Lentz, K.A., Lelas, S., Li,...> ;J Med Chem. 2009-12-10
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.
Hartz, R.A., Ahuja, V.T., Rafalski, M., Schmitz, W.D., Brenner, A.B., Denhart, D.J., Ditta, J.L., Deskus, J.A., Yue, E.W., Arvanitis, A.G., Lelas, S., Li, Y., Molski, ...> ;J Med Chem. 2009-07-23
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.
Hartz, R.A., Ahuja, V.T., Arvanitis, A.G., Rafalski, M., Yue, E.W., Denhart, D.J., Schmitz, W.D., Ditta, J.L., Deskus, J.A., Brenner, A.B., Hobbs, F.W., Payne, J., Lel...> ;J Med Chem. 2009-07-23
Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.
Mattson, R.J., Catt, J.D., Denhart, D.J., Deskus, J.A., Ditta, J.L., Higgins, M.A., Marcin, L.R., Sloan, C.P., Beno, B.R., Gao, Q., Cunningham, M.A., Mattson, G.K., Mo...> ;J Med Chem. 2005 Sep 22
Catalytic asymmetric diazoacetate cyclopropanation of 1-tosyl-3-vinylindoles. A route to conformationally restricted homotryptamines.
Marcin, L. R.,Denhart, D. J.,Mattson, R. J.> ;Org Lett. 2005 Jun 23
Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130.
Taber, M. T.,Wright, R. N.,Molski, T. F.,Clarke, W. J.,Brassil, P. J.,Denhart, D. J.,Mattson, R. J.,Lodge, N. J.> ;Pharmacol Biochem Behav. 2005 Mar
6 citations
Surgical approach to anterior scalenectomy.
Ronald J Mattson> ;Hand Clinics. 2004 Feb 1
Evaluation of 99mTc-labeled iminodiacetic acid derivatives of substituted 2-aminopyrroles as hepatobiliary imaging agents in rats II.
Graham, B. W., Dejuliis, C. M., Mattson, R. J., Sowell, J. W.> ;J Pharm Sci. 1982 Mar
Evaluation of 99mTc-labeled iminodiacetic acid derivatives of substituted 2-aminopyrroles as hepatobiliary imaging agents. I.
DeJuliis, C. M., Graham, B. W., Mattson, R. J., Sowell, J. W.> ;J Pharm Sci. 1980 Jun
Synthesis of alkylaminoalkylamides of substituted 2-aminopyrroles as potential local anesthetic and antiarrhythmic agents I: alpha-Amines.
Sowell, J. W., Block, A. J., Derrick, M. E., Freeman, J. J., Kosh, J. W., Mattson, R. J., Mubarak, P. F., Tenthorey, P. A.> ;J Pharm Sci. 1981 Feb
[3H]5-carboxamidotryptamine labels multiple high affinity 5-HT1D-like sites in guinea pig brain.
Mahle, C. D., Nowak, H. P., Mattson, R. J., Hurt, S. D., Yocca, F. D.> ;Eur J Pharmacol. 1991 Dec 3
In vivo disposition and in vitro metabolism of an anxiolytic compound, BMS-184111, in rats.
Yeleswaram, K., Volk, K. J., Rourick, R., Catt, J. D., Mattson, R. J., McGoff, K. B., Knipe, J. O.> ;Res Commun Mol Pathol Pharmacol. 1995 Jul
Enantioselective synthesis of a highly potent selective serotonin reuptake inhibitor. An application of imidazolidinone catalysis to the alkylation of indoles with an ...
King, H. D., Meng, Z., Denhart, D., Mattson, R., Kimura, R., Wu, D., Gao, Q., Macor, J. E.> ;Org Lett. 2005 Aug 4
Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides.
Epperson, J. R., Bruce, M. A., Catt, J. D., Deskus, J. A., Hodges, D. B., Karageorge, G. N., Keavy, D. J., Mahle, C. D., Mattson, R. J., Ortiz, A. A., Parker, M. F., T...> ;Bioorg Med Chem. 2004 Sep 1
Ligand conformation has a definitive effect on 5-HT1A and serotonin reuptake affinity.
Boy, K. M., Dee, M., Yevich, J., Torrente, J., Gao, Q., Iben, L., Stark, A., Mattson, R. J.> ;Bioorg Med Chem Lett. 2004 Sep 6
Diaminopyrimidine and diaminopyridine 5-HT7 ligands.
Denhart, D. J., Purandare, A. V., Catt, J. D., King, H. D., Gao, A., Deskus, J. A., Poss, M. A., Stark, A. D., Torrente, J. R., Johnson, G., Mattson, R. J.> ;Bioorg Med Chem Lett. 2004 Aug 16
Aminotriazine 5-HT7 antagonists.
Mattson, R. J., Denhart, D. J., Catt, J. D., Dee, M. F., Deskus, J. A., Ditta, J. L., Epperson, J., Dalton King, H., Gao, A., Poss, M. A., Purandare, A., Tortolani, D....> ;Bioorg Med Chem Lett. 2004 Aug 16
Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.
Sun, L. Q., Chen, J., Mattson, R. J., Epperson, J. R., Deskus, J. A., Li, W. S., Takaki, K., Hodges, D. B., Iben, L., Mahle, C. D., Ortiz, A., Molstad, D., Ryan, E., Y...> ;Bioorg Med Chem Lett. 2003 Dec 15
Indanyl piperazines as melatonergic MT2 selective agents.
Mattson, R. J., Catt, J. D., Keavy, D., Sloan, C. P., Epperson, J., Gao, Q., Hodges, D. B., Iben, L., Mahle, C. D., Ryan, E., Yocca, F. D.> ;Bioorg Med Chem Lett. 2003 Mar 24
Development of a presynaptic 5-HT1A antagonist.
Mattson, R. J., Catt, J. D., Sloan, C. P., Gao, Q., Carter, R. B., Gentile, A., Mahle, C. D., Matos, F. F., McGovern, R., VanderMaelen, C. P., Yocca, F. D.> ;Bioorg Med Chem Lett. 2003 Jan 20
Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs).
Schmitz, W. D., Denhart, D. J., Brenner, A. B., Ditta, J. L., Mattson, R. J., Mattson, G. K., Molski, T. F., Macor, J. E.> ;Bioorg Med Chem Lett. 2005 Mar 15
Join now to see all

Professional Memberships

American College of Surgeons - ACS
Member

Hospital Affiliations

Bryn Mawr HospitalBryn Mawr, Pennsylvania
Paoli HospitalPaoli, Pennsylvania